Invitrogen CEO Greg Lucier and Alnylam Pharmaceuticals President and Chief Executive Officer John Maraganore and have been appointed to the board of directors of the Biotechnology Industry Organization. Maraganore and Lucier will serve three-year terms.

Susan Siegel has resigned as president of Affymetrix, the company announced last week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.